Patents Assigned to THE ANGIOGENESIS FOUNDATION
  • Publication number: 20200316037
    Abstract: The invention relates to unique compositions and methods for treating neoplasia. Specifically, the invention relates to an off-label combinatorial therapy that modulates angiogenesis and immune response to treat neoplasia.
    Type: Application
    Filed: December 21, 2018
    Publication date: October 8, 2020
    Applicant: THE ANGIOGENESIS FOUNDATION
    Inventors: Vincent W. LI, William W. LI